Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for Von Willebrand Disease (VWD)
Sites in Morrisville +10 more locations
Sponsor: Vega Therapeutics, Inc
Sex: All·Age: 12 - 75
Code: NCT07115004·Phase 3·Recruiting·Listed Aug 2025